Prevenciónal a tüdorák okozta halálozás visszaszorításáért

Translated title of the contribution: Reducing lung cancer mortality through prevention

G. Kovács, G. Ostoros, G. Pataki

Research output: Contribution to journalShort survey

1 Citation (Scopus)


Effective therapy for lung cancer is yet unknown and the role of prevention has continuously increased. In practice, primary prevention of lung cancer means the reduction of smoking either by cessation or by patient education. Screening for lung cancer, considered as a secondary prevention measure, has long been debated. The previously negative attitude for screening has slowly changed in the past years. New studies have been organised recently to make screening more effective. In high risk groups, helical CT-scans with low dose X-ray exposure are preferred and the effectivity of sputum citology completed with immunocytochemical tests is under investigation. Determining the risk group, we focus on age, smoking history, airway obstruction and certain tumour markers. With the help of traditional chest X-rays approximately one third of new cases of lung cancer are discovered in Hungary. Our reasonable target is to identify 60-70% of the new NSCLC cases by risk group screening (age>40 years, smoking>20 P.Y., decrease of FEV1>15%, family lung cancer history and previous asbestos exposure) and by organising population screening more effectively.

Translated title of the contributionReducing lung cancer mortality through prevention
Original languageHungarian
Pages (from-to)268-273
Number of pages6
JournalLege Artis Medicinae
Issue number4
Publication statusPublished - Jul 3 2001

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Reducing lung cancer mortality through prevention'. Together they form a unique fingerprint.

  • Cite this